Itamar Medical Ltd. ITMR
30.87 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
30.75 Day range 30.91
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 30.75 -0.4% downside
Now 30.87
- Target (low)
- 30.00
- Target (mean)
- 30.75
- Target (high)
- 31.00
Ratings (-1m) 5 1 buy · 4 hold · 0 sell
- Strong buy0
- Buy1
- Hold4
- Sell0
- Strong sell0
Recommendation trend
- 1 month ago 5
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.27 | -0.30 – -0.22 | -0.20 | -35.0% | 13.40M | 0.0% | 3 |
| Next quarter | -0.21 | -0.26 – -0.17 | -0.21 | 0.0% | 15.55M | +21.8% | 3 |
| Current year | -1.16 | -1.20 – -1.12 | -0.79 | -46.8% | 53.50M | +30.4% | 2 |
| Next year | -0.50 | -0.71 – -0.29 | -1.16 | +56.9% | 69.54M | +30.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 20, 2021 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Sep 15, 2021 | Ladenburg Thalmann | Downgrade | Buy | Neutral |
| Sep 14, 2021 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Sep 14, 2021 | Cowen & Co. | Downgrade | Outperform | Market Perform |
| May 20, 2021 | SVB Leerink | Maintained | — | Outperform |
| Mar 8, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 18, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Aug 17, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Jun 12, 2020 | SVB Leerink | Initiated | — | Outperform |
| Mar 23, 2020 | H.C. Wainwright | Initiated | — | Buy |
| Feb 5, 2020 | Piper Sandler | Initiated | — | Overweight |
| Aug 29, 2019 | Alliance Global Partners | Initiated | — | Buy |